{"id":46242,"date":"2022-07-15T17:01:37","date_gmt":"2022-07-15T15:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/"},"modified":"2022-07-15T17:01:37","modified_gmt":"2022-07-15T15:01:37","slug":"1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/","title":{"rendered":"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 &#8211; Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5615312\/oncology-based-in-vivo-cro-market-global?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=tkr22r&amp;utm_campaign=1727063+-+%241.6+Billion+Worldwide+Oncology+Based+In-Vivo+CRO+Industry+to+2027+-+Featuring+Crown+Bioscience%2C+Eurofins+Scientific+and+Evotec+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1.69 Billion by 2027, exhibiting a CAGR of 8.26% during 2021-2027.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nChampions Oncology Inc.\n<\/li>\n<li>\nCharles River Laboratories International Inc.\n<\/li>\n<li>\nCrown Bioscience Inc.\n<\/li>\n<li>\nEurofins Scientific\n<\/li>\n<li>\nEvotec SE\n<\/li>\n<li>\nICON Plc\n<\/li>\n<li>\nLabcorp Drug Development (Laboratory Corporation of America Holdings)\n<\/li>\n<li>\nLiving Tumor Laboratory\n<\/li>\n<li>\nTaconic Biosciences Inc.\n<\/li>\n<li>\nThe Jackson Laboratory\n<\/li>\n<li>\nWuXi AppTec\n<\/li>\n<li>\nXentech\n<\/li>\n<\/ul>\n<p>\nKeeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.\n<\/p>\n<p>\nOncology refers to a branch of medicine that studies, diagnoses, and treats cancer using biopsy, endoscopy, X-ray, computed tomography (CT) scanning, magnetic resonance imaging (MRI), positron emission tomography (PET) scanning, and ultrasound. It offers hormonal therapy, immunotherapy, radiotherapy, and oral therapies to patients for tolerating and easing the side effects of cancer. At present, there is a rise in the demand for oncology based in-vivo CRO across the globe due to the development of several investigational compounds by contract research organizations (CROs) for treating cancer.\n<\/p>\n<p>\nThe growing prevalence of cancer around the world represents one of the key factors driving the market. Moreover, governments of several countries across the globe are extensively investing in research and development (R&amp;D) activities. This, along with the rising expertise in cancer treatment by contract research organizations (CROs), is propelling the growth of the market. In addition, there is an increase in the innovation of genetic engineering for manipulating deoxyribonucleic acid (DNA) and altering the characteristics of organisms.\n<\/p>\n<p>\nThis, coupled with the growing focus on oncogene study to regulate proliferation, growth, and differentiation of cells, is positively influencing the market. Besides this, the wide availability of medicines, along with the expanding healthcare industry, is catalyzing the demand for oncology based in-vivo CRO worldwide.\n<\/p>\n<p>\nApart from this, the cost-efficiency offered by contract research organizations (CROs) compared to an in-house study is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the adoption of telehealth and virtual clinical trials in the healthcare industry for ensuring the safety of cancer patients. This is projected to bolster the growth of the market.\n<\/p>\n<p>\n<strong>Key Questions Answered in This Report:<\/strong>\n<\/p>\n<ul>\n<li>\nHow has the global oncology based in-vivo CRO market performed so far and how will it perform in the coming years?\n<\/li>\n<li>\nWhat has been the impact of COVID-19 on the global oncology based in-vivo CRO market?\n<\/li>\n<li>\nWhat are the key regional markets?\n<\/li>\n<li>\nWhat is the breakup of the market based on the indication?\n<\/li>\n<li>\nWhat is the breakup of the market based on the model?\n<\/li>\n<li>\nWhat is the breakup of the market based on the application?\n<\/li>\n<li>\nWhat are the various stages in the value chain of the industry?\n<\/li>\n<li>\nWhat are the key driving factors and challenges in the industry?\n<\/li>\n<li>\nWhat is the structure of the global oncology based in-vivo CRO market and who are the key players?\n<\/li>\n<li>\nWhat is the degree of competition in the industry?\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Preface<\/strong>\n<\/p>\n<p>\n<strong>2 Scope and Methodology<\/strong>\n<\/p>\n<p>\n<strong>3 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>4 Introduction<\/strong>\n<\/p>\n<p>\n4.1 Overview\n<\/p>\n<p>\n4.2 Key Industry Trends\n<\/p>\n<p>\n<strong>5 Global Oncology Based In-Vivo CRO Market<\/strong>\n<\/p>\n<p>\n5.1 Market Overview\n<\/p>\n<p>\n5.2 Market Performance\n<\/p>\n<p>\n5.3 Impact of COVID-19\n<\/p>\n<p>\n5.4 Market Forecast\n<\/p>\n<p>\n<strong>6 Market Breakup by Indication<\/strong>\n<\/p>\n<p>\n<strong>7 Market Breakup by Model<\/strong>\n<\/p>\n<p>\n<strong>8 Market Breakup by Application<\/strong>\n<\/p>\n<p>\n<strong>9 Market Breakup by Region<\/strong>\n<\/p>\n<p>\n<strong>10 SWOT Analysis<\/strong>\n<\/p>\n<p>\n<strong>11 Value Chain Analysis<\/strong>\n<\/p>\n<p>\n<strong>12 Porters Five Forces Analysis<\/strong>\n<\/p>\n<p>\n<strong>13 Price Analysis<\/strong>\n<\/p>\n<p>\n<strong>14 Competitive Landscape<\/strong>\n<\/p>\n<p>\n14.1 Market Structure\n<\/p>\n<p>\n14.2 Key Players\n<\/p>\n<p>\n14.3 Profiles of Key Players\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5615312\/oncology-based-in-vivo-cro-market-global?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=tkr22r&amp;utm_campaign=1727063+-+%241.6+Billion+Worldwide+Oncology+Based+In-Vivo+CRO+Industry+to+2027+-+Featuring+Crown+Bioscience%2C+Eurofins+Scientific+and+Evotec+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/svtj05<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;&#111;&#x3a;&#112;&#x72;&#101;s&#x73;&#64;&#x72;&#101;&#x73;&#101;&#x61;&#114;&#x63;&#104;a&#x6e;d&#x6d;&#97;&#x72;&#107;&#x65;&#116;s&#x2e;c&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">press&#64;&#114;&#101;&#115;&#101;&#97;&#114;&#99;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;com<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1.69 Billion &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46242","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 - Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 - Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1.69 Billion ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-15T15:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 &#8211; Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-15T15:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/\"},\"wordCount\":682,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005333\\\/en\\\/1515099\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/\",\"name\":\"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 - Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005333\\\/en\\\/1515099\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-15T15:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005333\\\/en\\\/1515099\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220715005333\\\/en\\\/1515099\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 &#8211; Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 - Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 - Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Oncology Based In-Vivo CRO Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global oncology based in-vivo CRO market reached a value of US$ 1.05 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 1.69 Billion ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-15T15:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 &#8211; Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-07-15T15:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/"},"wordCount":682,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/","name":"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 - Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/21\/logo.jpg","datePublished":"2022-07-15T15:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220715005333\/en\/1515099\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/1-6-billion-worldwide-oncology-based-in-vivo-cro-industry-to-2027-featuring-crown-bioscience-eurofins-scientific-and-evotec-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"$1.6 Billion Worldwide Oncology Based In-Vivo CRO Industry to 2027 &#8211; Featuring Crown Bioscience, Eurofins Scientific and Evotec Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46242","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46242"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46242\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46242"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46242"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46242"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}